KAPOSI SARCOMA
Clinical trials for KAPOSI SARCOMA explained in plain language.
Never miss a new study
Get alerted when new KAPOSI SARCOMA trials appear
Sign up with your email to follow new studies for KAPOSI SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a pill and IV combo tame Virus-Linked cancers?
Disease control Recruiting nowThis early-phase study tests a combination of two drugs—pomalidomide (a pill) and nivolumab (an IV infusion)—in adults with cancers caused by viruses like Epstein-Barr, HPV, or hepatitis. The goal is to find a safe dose and see if the drugs can shrink tumors or slow disease. Part…
Matched conditions: KAPOSI SARCOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 00:36 UTC
-
Could a protein boost immune cells and fight cancer in HIV patients?
Disease control Recruiting nowThis study tests a lab-made protein called CYT107 in 55 adults with HIV-related Kaposi sarcoma who have low T-cell counts. The goal is to see if weekly injections for up to 4 weeks can shrink tumors by boosting the immune system. Participants who improve may receive another round…
Matched conditions: KAPOSI SARCOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 29, 2026 00:34 UTC